EBS:NYSE
Emergent Biosolutions Inc
US$6,98
arrow_downward
-1,13%(-0,080) 1D
US$7,00
arrow_upward
+0,29% (+0,020)todayPre-market
Closed: 12 ຕ.ລ., 16 ໂມງ 0 ນາທີ 02 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EBS...
Open
US$7,08
High
US$7,33
Low
US$6,95
Mkt. cap
357,89 ລ້ານ
Avg. vol.
1,16 ລ້ານ
Volume
4,96 ພັນ
52-wk high
US$14,06
52-wk low
US$4,36
EPS
US$-3,51
Beta
2,28
Shares outstanding
51,27 ລ້ານ
No. of employees
900
Open
US$7,08
High
US$7,33
Low
US$6,95
Mkt. cap
357,89 ລ້ານ
Avg. vol.
1,16 ລ້ານ
Volume
4,96 ພັນ
52-wk high
US$14,06
52-wk low
US$4,36
EPS
US$-3,51
Beta
2,28
Shares outstanding
51,27 ລ້ານ
No. of employees
900
News stories
From web sources and news partners
MarketBeat
·
7 ນາທີກ່ອນ
GitLab Inc. (NASDAQ:GTLB) Stock Now Rated "Hold" by Wall Street Analysts
TradingView
·
25 ນາທີກ່ອນ
Nasdaq Futures Sink, Dow Rises Premarket As AI Chip Stocks Wobble Ahead Of Big Bank Earnings: MU, SNDK, NVTS, NVDA, SPCX, ASTS, UNH, V Stocks In Focus
Markets Media
·
35 ນາທີກ່ອນ
HKEX Offers S&P 500 & HKEX Tech 100 Index
Yahoo Finance
·
5 ຊົ່ວໂມງກ່ອນ
Citi Says S&P 500 Needs AI and Non-AI Stocks to Reach 8,100
Profile
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
About Emergent Biosolutions Inc
CEORobert G. Kramer Sr. | Joseph C. Papa
Employees900
Founded5 ກ.ຍ. 1998
HeadquartersRockville, ແມຣີແລນ, ສະຫະລັດ
SectorBiotechnology
Websiteemergentbiosolutions.com